Sign in →

Test Code LAB2848 Bivalirudin Level

Important Note

Capillary blood (e.g. heel stick or finger prick) samples are not acceptable for coagulation testing because of the potential for contamination with tissue factor, dilution with tissue fluid, and difficulty with filling tubes to adequate volume. Coagulation assays have not been validated for capillary blood samples.

Clinical System Name

Bivalirudin Level
 

Synonyms

LAB2848

BIVAL

DTI Level

Direct Thrombin Inhibitor Level

 

Sample Requirements

Specimen: Whole Blood

Container(s): Lt Blue/Citrate

Required Vol: one 1.8 mL tube or one 2.7 mL tube (do NOT over or under fill)

Minimum Vol: N

 

Note:  This is enough for Bivalirudin, PTT, TT, and Fibrinogen on the same sample. Preferred method of collection is venipuncture with vacuum fill. Test results are affected by incorrect blood volume. Use of a Vascular Access Device for the collection of coag testing is not recommended.

 

If a venipuncture is not possible and drawing from a line is necessary:

a. Draw from a line not used to infuse Bivalirudin, if possible. 

b. If drawing from a line used to infuse Bivalirudin, waste the following volume:

   A 6-mL waste volume for PIVs, PICCs, temporary venous lines (femoral, jugular) and Baby Broviacs.

  A 12-mL waste volume for all other permanent lines (Hickman, Portacath, HD, tunneled lines).

Processing Instructions

Main Campus CPA: Core Technologist will process specimen. Deliver blood directly to Core Coag bench.

 

Reject due to: Clotted, Insufficient quantity (underfill), or Improper collection (overfill).

Spin: Y

Aliquot: Y

Storage location: Core 14 Freezer ( -70 C).

 

Core Technologist: Specimen should be centrifuged within 1 hour of collection. Spin whole blood, remove plasma. Transfer upper 3/4 layer of plasma to plastic tube affixed with large computer label.

 

Off-site collection: Preferred method of collection is venipuncture with vacuum fill. Test results are affected by incorrect blood volume, note the fill line on the tube. Use of a Vascular Access Device for the collection of coag testing is not recommended. If this method is used it requires a 5 mL waste volume; 3 mL for size 2 French catheter or smaller. Blood must be transferred to the Lt Blue/Citrate tube by use of the blood transfer device.

 

Specimen should be centrifuged within 1 hour of collection. Double spin, transfer upper 3/4 layer of plasma to plastic tube affixed with large computer label. Freeze until solid one aliquot of 1.0 mL plasma in plastic tube at -70C (preferred) or -20C.

 

Non-Children's Hospital Off-site collection: Ship completely frozen on dry ice.

 

Children's Regional Clinics: Ship completely frozen in frozen Nalgene Labtop cooler with ice pack inside an insulated soft cooler.

Stability

Specimen Type Temperature Time
Citrated platelet-poor plasma Room temp ≤ 4 h
  Refrigerated N
  Frozen   -20 C or -70 C ≤ 3 m

 

Availability

STAT Performed TAT
Y

Daily

1 h

 

Performing Laboratory

Seattle Children's Laboratory    

 

Department

Department:  Coagulation

Phone Number: 206 987-2617 (Client Services)

 

 

 

CPT Codes

80299

Methodology

Method: Electromagnetic mechanical clot detection system by STA-R MAX

Analytical Volume: 1 mL plasma

This is enough for Bivalirudin, PTT, TT, and Fibrinogen on the same sample.

 

Limitations: Method is affected by improper collection, processing and storage.

High hematocrit greater than or equal to 56% requires a citrate adjusted tube.

Reference Range

Therapeutic Range: 0.7 - 1.5  µg/mL.

Cardiopulmonary Bypass Patients: 5.0 - 20 µg/mL.

Description

Bivalirudin is used for prophylaxis or treatment of thrombosis in patients with heparin induced thrombocytopenia (HIT). The quantitative determination of plasma Bivalirudin levels is useful for monitoring treatment efficacy.

Critical Values

Not defined for this test.